The Crohn's & Colitis Foundation is hosting its An Evening of Hope gala virtually Oct. 24 to support the Philadelphia/Delaware Valley Chapter.
GI & Endoscopy
CMS issued a proposal which declined to cover the first FDA-approved blood-based colorectal cancer screening test, but created a guideline for still-in-development tests to earn approval, according to an Oct. 16 memo.
In Wisconsin, Epic and Exact Sciences are decreasing COVID-19 test turnaround time by inputting results directly into Epic's MyChart program, Channel3000 reports.
Tucson-based University of Arizona researchers have identified a biomarker that appears in patients before they develop stomach cancer, the university announced Oct. 20.
Screening delays this year could lead to uptick in colorectal cancer mortality — 5 GI industry notes
Here are five updates from gastroenterology companies and practices from the past week:
A low-residue diet is a viable alternative to clear-liquid diet preparation, and gastroenterologists should be paying more attention to it, said David Johnson, MD, chief of gastroenterology at Eastern Virginia Medical School in Norfolk.
Marysville, Ill.-based Memorial Health opened its $50 million Memorial 2020 project, which developed a new inpatient and outpatient facility, the Urbana Daily Citizen reports.
Healthgrades released its Healthgrades Specialty Excellence Awards and Best Hospitals for Specialty Care report Oct. 20, recognizing several facilities for top-line care.
Here are four new GI-driven ASCs and facilities that were opened or announced in September:
Sarasota (Fla.) Memorial Health Care System opened an outpatient center with an endoscopy suite Oct. 15, SRQ Magazine reports.
